Targeting cytotoxic T-lymphocyte antigen
β
Steven J. O'Day; Omid Hamid; Walter J. Urba
π
Article
π
2007
π
John Wiley and Sons
π
English
β 511 KB
## Abstract Cancer immunotherapy centers on modulating the host's tumorβdirected immune response. One promising approach involves augmentation of cellβmediated immunity by interrupting Tβcell pathways responsible for immune downβregulation or tolerance. The discovery of cytotoxic Tβlymphocyte antig